Skip to content

Clinical trials

Phase 2 Heart Failure trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2 Country / region: Bulgaria Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20134
20161
20173
20181
20191
20201
20211
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
AstraZeneca3
Novartis Pharmaceuticals3
Cardurion Pharmaceuticals, Inc.2
Akros Pharma Inc.1
AskBio Inc1
Cytokinetics1
Pfizer1
Regeneron Pharmaceuticals1
Stealth BioTherapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure20
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
Heart Diseases2
Diabetes Mellitus1
Diabetic Nephropathies1
Dyspnea1
Edema1
Heart Failure, Diastolic1
Hyperglycemia1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.